Medical Device Coatings Companies

November 2023

Surmodics Inc. has introduced Preside hydrophilic medical device coating technology to the market. The next-generation neurovascular, coronary, and peripheral vascular devices are designed to use Preside hydrophilic coatings, which combine improved lubricity with durability.

In order to improve distal access for neurovascular applications and crossing for difficult coronary lesions or chronic total occlusions, Preside, according to the company, is a low-friction, low-particulate generation coating that enhances Surmodics' existing Serene hydrophilic coatings.

Rising regulatory requirements are also addressed by Preside's enhanced particulate reduction. Furthermore, customers can utilise their current coating processes to take advantage of Preside hydrophilic coatings, making it simple to implement in a manufacturing setting.

Preside hydrophilic coatings, according to Surmodics, adhere to a broad range of substrates found in top-selling peripheral, coronary, and neurovascular catheters.

Using Surmodics' Photolink ultraviolet (UV) curing process, which covalently bonds surface treatments to substrates at room temperature, principal hydrophilic coatings are applied.  

November 2023

Researchers from the University of St Andrews in Scotland and Colorado State University have created a flexible and potent antimicrobial material that can be applied to internal medical devices.

In order to create metal-organic frameworks—three-dimensional crystalline materials composed of metals and linkers that are porous and stable in water—the work integrates earlier research from both universities. In order to gradually release nitric oxide, the teams integrated their two frameworks into a single thin-film membrane. Nitric oxide is a well-known antimicrobial agent that the body naturally produces. It not only kills bacteria and fungus immediately upon contact, but it also keeps killing them for a long time.

Major Medical Device Coatings market players include Speciality Coating Systems Inc (U.S.), Royal DSM N.V. (The Netherlands), and Biocoat Incorporated (U.S.).Surmodics Inc. (U.S.), and others, are attempting to increase market demand by funding R&D initiatives.